An introduction to epitope prediction methods and software

Reviews in Medical Virology

Volumn 19, Issue 2, 2009, Pages 77-96

  Yang, Xingdong ^a   Yu, Xinglong ^a  

^a HUNAN AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1;

B LYMPHOCYTE; COMPUTER ANALYSIS; COMPUTER PREDICTION; DATA ANALYSIS SOFTWARE; EPITOPE MAPPING; INTERMETHOD COMPARISON; INTERNET; MAJOR HISTOCOMPATIBILITY COMPLEX; ONLINE SYSTEM; PREDICTION; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; SEQUENCE ANALYSIS; T LYMPHOCYTE;

ALGORITHMS; COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; HUMANS; MODELS, MOLECULAR; SOFTWARE;

EID: 64049090391     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.602     Document Type: Review

References (149)

1. De Groot AS. Immunomics: discovering new targets for vaccines and therapeutics. Drug Discov Today 2006; 11(5/6): 203-209.
2. Pellequer JL, Westhof E, Van Regenmortel MHV. Predicting location of continuous epitopes in proteins from their primary structures. Methods Enzymol 1991; 203(8): 176-201
3. Zhao B, Sakharkar KR, Lim CS, Kangueane P, Sakharkar MK. MHC-peptide binding prediction for epitope based vaccine design. IJIB 2007; 1(2): 127-140.
4. Tong JC, Tan TW, Ranganathan S. Methods and protocols for prediction of immunogenic epitopes. Brief Bioinform 2007; 8(2): 96-108.
5. Korber B, LaBute M, Yusim K. Immunoinformatics comes of age. PLoS Comput Biol 2006; 2(6): 484-492.
6. Rick R. Review of immunoinformatic approaches to in-silico B-cell epitope prediction. Available from Nature Precedings http://dx.doi.org/ 10.1038/npre.2007.253.1>(2007)
7. Hanada K, Yewdell JW, Yang JC. Immune recognition of a human renal cancer antigen through post-translational protein splicing. Nature 2004; 427: 252-256.
8. Yewdell JT, Bennink JR. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Ann Rev Immunol 1999; 17: 51-88.
9. Macallum RM, Martin ACR, Thornton JM. Antibody-antigen interactions: contact analysis and binding site topography. J Mol Biol 1996; 262: 732-745.
10. Almagro JC. Identification of differences in the specificity-determining residues of antibodies that recognize antigens of different size. J Mol Rec 2004; 17: 132-143.
11. αβT cell receptor diversity. Science 1999; 286(5441): 958-961.
12. Jerne NK. The nobel lectures in immunology. The nobel prize for physiology or medicine, 1984. The generative grammar of the immune system. Scand J Immunol 1993; 38(1): 1-9.
13. Welling GW, Weijer WJ, van der Zee R, Welling-Wester S. Prediction of sequential antigenic regions in proteins. FEBS Lett 1985; 188(2): 215-218.
14. Parker JM, Guo D, Hodges RS. New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry 1986; 25(19): 5425-5432.
15. Kolaskar AS, Tongaonkar PC. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 1990; 276(1-2): 172-174.
16. Kolaskar AS, Kulkarni-Kale U. Prediction of three-dimensional structure and mapping of conformational epitopes of envelope glycoprotein of Japanese encephalitis virus. Virology 1999; 261(1): 31-42.
17. Margalit H, Spouge JL, Cornette JL, Cease KB, Delisi C, Berzofsky JA. Prediction of immunodominant helper T cell antigenic sites from the primary sequence. J Immunol 1987; 138: 2213-2229.
18. Rothbard JB, Taylor WR. A sequence pattern common to T cell epitopes. EMBO J 1988; 7(1): 93-100.
19. Stille CJ, Thomas LJ, Reyes VE, Humphreys RE. Hydrophobic strip-of-helix algorithm for selection of T cell-presented peptides. Mol Immunol 1987; 24(10): 1021-1027.
20. Sturniolo T, Bono E, Ding J, et al. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol 1999; 17(6): 533-534.
21. Brusic V, Rudy G, Honeyman G, Hammer J, Harrison L. Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network. Bioinformatics 1998; 14: 121-130.
22. Murugan N, Dai Y. Prediction of MHC class II binding peptides based on an iterative learning model. Immunome Res 2005; 1: 6.
23. Doytchinova IA, Taylor P, Flower DR. Proteomics in vaccinology and immunobiology: an informatics perspective of the immunone. J Biomed Biotechnol 2003; 5(2003): 267-290.
24. Yu K, Petrovsky N, Schönbach C, Koh JYL, Brusic V. Methods for prediction of peptide binding to MHC molecules: a comparative study. Mol Med 2002; 8(3): 137-148.
25. Bhasin M, Raghava GP. Prediction of CTL epitopes using QM, SVM and ANN techniques. Vaccine 2004; 22: 3195-3204.
26. Zhang Q, Wang P, Kim Y, et al. Immune epitope database analysis resource (IEDB-AR). Nucleic Acids Res 2008; 36: W513-W518.
27. Brown MPS, Grundy WN, Lion D, et al. Knowledge-based analysis on microarray gene expression data by using support vector machines. Proc Natl Acad Sci 2000; 97: 262-297.
28. Rosenberg HF, Dyer KD. Eosinophil cationic protein and eosinophil-derived neurotoxin. Evolution of novel function in a primate ribonuclease gene family. J Biol Chem 1995; 270(37): 21539-21544.
29. Altuvia Y, Schueler O, Margalit H. Ranking potential binding peptides to MHC molecules by a computational threading approach. J Mol Biol 1995; 249: 244-250.
30. Schueler-Furman O, Altuvia Y, Sette A, Margalit H. Structure-based prediction of binding peptides to MHC class I molecules: application to a broad range of MHC alleles. Protein Sci 2000; 9: 1838-1846.
31. Michielin O, Luescher I, Karplus M. Modeling the TCR-MHC-peptide complex. J Mol Biol 2000; 300: 1205-1235.
32. Rosenfeld R, Zheng Q, Vajda S, DeLisi C. Computing the structure of bound peptides. Application to antigen recognition by class I major histocompatibility complex receptors. J Mol Biol 1993; 234(3): 515-521.
33. Sezerman U, Vajda S, DeLisi C. Free energy mapping of class IMHC molecules and structural determination of bound peptides. Protein Sci 1996; 5: 1272-1281.
34. Rognan D, Laumoeller SL, Holm A, Buus S, Tschinke V. Predicting binding affinities of protein ligands from three-dimensional models: application to peptide binding to class I major histocompatibility proteins. J Med Chem 1999; 42: 4650-4658.
35. Desmet J, Maeyer MD, Spriet J, Lasters I. Flexible docking of peptide ligands to proteins. Methods Mol Biol 2000; 143: 359-376.
36. Tong JC, Tan TW, Ranganathan S. Modeling the structure of bound peptide ligands to major histocompatibility complex. Protein Sci 2004; 13(9): 2523-2532.
37. Greenbaum JA, Andersen PH, Blythe M, et al. Towards a consensus on datasets and evaluation metrics for developing B-cell epitope prediction tools. J Mol Recognit 2007; 20(2): 75-82.
38. Doytchinova IA, Guan P, Flower DR. EpiJen: a server for multistep T cell epitope prediction BMC Bioinformatics 2006; 7: 131.
39. Brusic V, Bajic VB, Petrovsky N. Omputational methods for prediction of T-cell epitopes - a framework for modelling, testing, and applications. Methods 2004; 34: 436-443.
40. Hopp TP, Woods KR. Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci USA 1981; 78: 3824-3828.
41. Welling GW, Weijer WJ, van der Zee R, Welling-Wester S. Prediction of sequential antigenic regions in proteins. FEBS Lett 1985; 188(2): 215-218.
42. Parker JM, Guo D, Hodges RS. New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry 1986; 25: 5425-5432.
43. Kolaskar AS, Tongaonkar PC. A semi empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 1990; 276(12): 172-174.
44. Alix AJ. Predictive estimation of protein linear epitopes by using the program PEOPLE. Vaccine 1999; 18: 311-314.
45. Ponomarenko JV, Bourne PE. Antibody-protein interactions: benchmark datasets and prediction tools evaluation. BMC Struct Biol 2007; 7: 64.
46. Sollner J, Grohmann R, Rapberger R, Perco P, Lukas A, Mayer B. Analysis and prediction of protective continuous b cell epitopes on pathogen proteins. BMC Immunome Res 2008; 4: 1.
47. Zhang CT, Chou KC. An analysis of protein folding type prediction by seed-propagated sampling and jackknife test. J Protein Chem 1995; 14: 583-593.
48. Larsen MV, Lundegaard C, Lamberth K, Buus S, Lund O, Nielsen M. Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics 2007; 8: 424.
49. Lin HH, Ray S, Tongchusak S, Reinherz EL, Brusic V. Evaluation of MHC class I peptide binding prediction servers: applications for vaccine research. BMC Immunol 2008; 9: 8.
50. Peters B, Bui HH, Frankild S, et al. A community resource benchmarking predictions of peptide binding to MHC-I molecules. PLoS Comput Biol 2006; 2(6): 574-584.
51. Trost B, Bickis M, Kusalik A. Strength in numbers: achieving greater accuracy in MHC-I binding prediction by combining the results from multiple prediction tools. Immunome Res 2007; 3: 5.
52. Rajapakse M, Schmidt B, Feng L, Brusic V. Predicting peptides binding to MHC class II molecules using multi-objective evolutionary algorithms. BMC Bioinformatics 2007; 8: 459.
53. Lo Conte L, Chothia C, Janin J. The atomic structure of protein-protein recognition sites. J Mol Biol 1999; 285(5): 2177-2198.
54. Jones S, Thornton JM. Principles of protein-protein interactions. Proc Natl Acad Sci U S A 1996; 93(1): 13-20.
55. Jones S, Thornton JM. Prediction of protein-protein interaction sites using patch analysis. J Mol Biol 1997; 272(1): 133-143.
56. Gowthaman U, Agrewala JN. In silico tools for predicting peptides binding to HLA-class II molecules: more confusion than conclusion. J Proteome Res 2008; 7: 154-163.
57. Borras-Cuesta F, Golvano J, Garcia-Granero M, et al. Specific and general HLA-DR binding motifs: comparison of algorithms. Hum Immunol 2000; 61: 266-278.
58. Wang P, Sidney J, Dow C, et al. A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Comput Biol 2008; 4(4): e1000048.
59. Cui J, Han LY, Lin HH, et al. Prediction of MHC-binding peptides of flexible lengths from sequence-derived structural and physicochemical properties. Mol Immunol 2007; 44(5): 866-877.
60. Lata S, Sharma BK, GPS Raghava. Analysis and prediction of antibacterial peptides. BMC Bioinformatics 2007; 8: 263.
61. Bui HH, Sidney J, Peters B, et al. Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications. Immunogenetics 2005; 57(5): 304-314.
62. Parker KC, Bednarek MA, Coligan JE. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 1994; 152: 163.
63. Holzhutter HG, Frommel C, Kloetzel PM. A theoretical approach towards the identification of cleavage-determining amino acid motifs of the 20 S proteasome. J Mol Biol 1999; 286: 1251-1265.
64. Tenzer S, Peters B, Bulik S, et al. Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding. Cell Mol Life Sci 2005; 62: 1025-1037.
65. Peters B, Bulik S, Tampe R, Van Endert PM, Holzhutter HG. Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors. J Immunol 2003; 171: 1741-1749.
66. Nielsen M, Lundegaard C, Worning P, et al. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci 2003; 12: 1007-1017.
67. Peters B, Sette A. Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method. BMC Bioinformatics 2005; 6: 132.
68. Wilson CC, McKinney D, Anders M, et al. Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1. J Immunol 2003; 171: 5611-5623.
69. Nielsen M, Lundegaard C, Lund O. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinformatics 2007 8: 238.
70. Sturniolo T, Bono E, Ding J, et al. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol 1999; 17: 555-561.
71. Singh H, Raghava GPS. Detection of orientation of MHC Class II Binding peptides using Bionformatics tools. Biotech Softw Internet Report, 2002; 3: 146.
72. Hakenberg J, Nussbaum AK, Schild H, et al. MAPPP: MHC class I antigenic peptide processing prediction. Appl Bioinformatics 2003; 2(3): 155-158.
73. Guan P, Doytchinova IA, Zygouri C, Flower DR. MHCPred: bringing a quantitative dimension to the online prediction of MHC binding. Appl Bioinformatics 2003; 2: 63-66.
74. Guan P, Doytchinova IA, Zygouri C, Flower DR. MHCPred: a server for quantitative prediction of peptide-MHC binding. Nucleic Acids Res 2003; 31: 3621-3624.
75. Hattotuwagama CK, Guan P, Doytchinova IA, Zygouri C, Flower DR. Quantitative online prediction of peptide binding to the major histocompatibility complex. J Mol Graph Model 2004; 22: 195-207.
76. Swain MT, Brooks AJ, Kemp GJL. An automated approach to modelling class II MHC alleles and predicting peptide binding. Proceedings of the Second IEEE International Symposium on Bio-Informatics and Biomedical Engineering. IEEE Computer Society Press, 2001; 81-88.
77. Bhasin M, Raghava GP. Prediction of promiscuous and high-affinity mutated MHC binders. Hybrid Hybridomics 2003; 22(4): 229-234.
78. Nielsen M, Lundegaard C, Lund O, Kesmir C. The role of the proteasome in generating cytotoxic T cell epitopes: insights obtained from improved predictions of proteasomal cleavage. Immunogenetics 2005; 57(1-2): 33-41.
79. Kesmir C, Nussbaum A, Schild H, Detours V, Brunak S. Prediction of proteasome cleavage motifs by neural networks. Prot Eng 2002; 15(4): 287-296.
80. Larsen MV, Lundegaard C, Lamberth K, et al. An integrative approach to CTL epitope prediction. A combined algorithm integrating MHC-I binding, TAP transport efficiency, and proteasomal cleavage predictions. Eur J Immunol 2005; 35(8): 2295-2303.
81. Buus S, Lauemoller SL, Worning P, et al. Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. Tissue Antigens 2003; 62: 378-384.
82. Nielsen M, Lundegaard C, Worning P, et al. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci 2003; 12: 1007-1017.
83. Nielsen M, Lundegaard C, Worning P, et al. Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach. Bioinformatics 2004; 20(9): 1388-1397.
84. Bhasin M, Raghava GPS. A hybrid approach for predicting promiscuous MHC class I restricted T cell epitopes. J Biosci 2006; 32: 31-42.
85. Nussbaum AK, Kuttler C, Hadeler KP, Rammensee HG, Schild H. PAProC: a prediction algorithm for proteasomal cleavages available on the WWW. Immunogenetics 2001; 53(2): 87-94.
86. Bhasin M, Raghava GP. Pcleavage: an SVM based method for prediction of constitutive proteasome and immunoproteasome cleavage sites in antigenic sequences. Nucleic Acids Res 2005; 33: W202-W207.
87. Singh H, Raghava GPS. ProPred: prediction of HLA-DR binding sites. Bioinformatics 2001; 17(12): 1236-1237.
88. Singh H, Raghava GP. ProPred1: prediction of promiscuous MHC Class-I binding sites. Bioinformatics 2003; 19(8): 1009-1014.
89. Reche PA, Glutting JP, Reinherz EL. Prediction of MHC class I binding peptides using profile motifs. Hum Immunol 2002; 63(9): 701-709.
90. Reche PA, Glutting JP, Zhang H, Reinherz EL. Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles. Immunogenetics 2004; 56(6): 405-419.
91. Bhasin M, Reinhez EL, Reche PA. Modeling features of immunodominance into T-cell epitope identification. 2nd International Immunoinformatics Symposium, Boston University, 7-9 March 2005.
92. Chang HT, Pai TW, Fan T, et al. A reinforced merging methodology for mapping unique peptide motifs in members of protein families. BMC Bioinformatics 2006; 7: 38.
93. Pai TW, Chang MD, Chang HT, et al. Unique peptide identification of RNaseA superfamily sequences based on reinforced merging algorithms. J Bioinform Comput Biol 2006; 4: 1.
94. Peters B, Tong W, Sidney J, Sette A, Weng Z. Examining the independent binding assumption for binding of peptide epitopes to MHC-I molecules. Bioinformatics 2003; 19: 1765-1772.
95. Dönnes P, Kohlbacher O. SVMHC: a server for prediction of MHC-binding peptides. Nucleic Acids Res 2006; 34(Web Server issue): W194-W197.
96. Bhasin M, Raghava GPS. Analysis and prediction of affinity of TAP binding peptides using cascade SVM. Protein Sci 2004; 13(3): 596-607.
97. Bian H, Hammer J. Discovery of promiscuous HLA-II-restricted T cell epitopes with TEPITOPE. Methods 2004; 34(4): 468-475.
98. Dönnes P, Kohlbacher O. Integrated modelling of the major events in the MHC class I antigen processing pathway. Protein Sci 2005; 14(8): 2132-2140.
99. Toseland CP, Clayton DJ, McSparron H, et al. Anti-Jen: a quantitative immunology database integrating functional, thermodynamic, kinetic, biophysical, and cellular data. Immunome Res 2005; 1: 4.
100. Reche PA, Zhang H, Glutting JP, Reinherz EL. EPIMHC: a curated database of MHC-binding peptides for customized computational vaccinology. Bioinformatics 2005; 21(9): 2140-2141.
101. Schönbach C, Koh JL, Sheng X, Wong L, Brusic V. FIMM, a database of functional molecular immunology. Nucleic Acids Res 2000; 28: 222-224.
102. Frahm N, Linde C, Brander C. Identification of HIV-Derived, HLA Class I Restricted CTL Epitopes: Insights into TCR Repertoire, CTL Escape and Viral Fitness. HIV Molecular Immunology, Korber BTM, Brander C, Haynes BF, Koup R, Moore JP, Walker BD, Watkins DI (eds). Los Alamos National Laboratory, Theoretical Biology and Biophysics: Los Alamos, New Mexico, 2006/2007; 3-28, LA-UR 07-4752.
103. Peters B, Sidney J, Bourne P, et al. The immune epitope database and analysis resource: from vision to blueprint. PLoS Biol 2005; 3(3): e91.
104. Robinson J, Waller MJ, Parham P, Bodmer JG, Marsh SGE. IMGT/HLA - a sequence database for the human major histocompatibility complex. Nucleic Acids Res 2001; 29: 210-213.
105. Giudicelli V, Duroux P, Ginestoux C, et al. IMGT/LIGM-DB, the IMGT comprehensive database of immunoglobulin and T cell receptor nucleotide sequences. Nucleic Acids Res 2006; 34: D781-D784.
106. Allcock RJ, Atrazhev AM, Beck S, et al. The MHC haplotype project: a resource for HLA-linked-association studies. Tissue Antigens 2002; 59: 520-521.
107. Bhasin M, Singh H, Raghava GPS. MHCBN: a comprehensive database of MHC binding and non-binding peptides. Nucleic Acids Res 2002; (online) http://www3.oup.co.uk/nar/database/summary/180
108. Bhasin M, Singh H, Raghava GPS. MHCBN: update 2002. Nucleic Acid Res 2003; (online, accepted).
109. Bhasin M, Singh H, Raghava GPS. MHCBN: a comprehensive database of MHC binding and non-binding peptides. Bioinformatics 2003; 19(5): 665-666.
110. Brusic V, Rudy G, Harrison LC. MHCPEP: a database of MHC-binding peptides. Nucleic Acids Res 1994; 22(17): 3663-3665.
111. Tong JC, Kong L, Tan TW, Ranganathan S. MPID-T: database for sequence-structure-function information on T-cell receptor/peptide/MHC interactions. Appl Bioinformatics 2006; 5(2): 111-114.
112. Berman HM, Westbrook J, Feng Z, et al. The protein data bank. Nucleic Acids Res 2000; 28: 235-242.
113. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovi S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999; 50(3-4): 213-219.
114. Saha S, Raghava GPS. Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins 2006; 65(1): 40-48.
115. Saha S, Raghava GPS. BcePred: Prediction of continuous B-cell epitopes in antigenic sequences using physico-chemical properties. In Artificial Immune Systems, Lecture Notes in Computer Science 3239, Nicosia G, Cutello V, Bentley PJ, Timis J (eds). Springer: Berlin, Heidelberg, 2004; 197-204.
116. Saha S, Bahsin M, Raghava GPS. Bcipep: a database of B-cell epitopes. BMC Genomics 2005; 6: 79.
117. Larsen JEP, Lund O, Nielsen M. Improved method for predicting linear B-cell epitopes. Immunome Res 2006; 2: 2.
118. Odorico M, Pellequer JL. BEPITOPE: predicting the location of continuous epitopes and patterns in proteins. J Mol Recognit 2003; 16(1): 20-22.
119. Sweredoski MJ, Baldi P. PEPITO: improved discontinuous B-cell epitope prediction using multiple distance thresholds and half sphere exposure. Bioinformatics 2008; 24(12): 1459-1460.
120. Huang J, Honda W. CED: a conformational epitope database. BMC Immunol 2006; 7: 7.
121. Kulkarni-Kale U, Bhosle S, Kolaskar AS. CEP: a conformational epitope prediction server. Nucleic Acids Res 2005; 33(Web Server issue): W168-W171.
122. Comeau SR, Gatchell DW, Vajda S, Camacho CJ. ClusPro: an automated docking and discrimination method for the prediction of protein complexes. Bioinformatics 2004; 20(1): 45-50.
123. Mandell JG, Roberts VA, Pique ME, et al. Protein docking using continuum electrostatics and geometric fit. Protein Eng 2001; 14(2): 105-113.
124. Glaser F, Pupko T, Paz I, et al. ConSurf: identification of functional regions in proteins by surface-mapping of phylogenetic information. Bioinformatics 2003; 19(1): 163-164.
125. Andersen PH, Nielson M, Lung O. Prediction of residues in discontinuous B-cell epitopes using protein 3D structures. Protein Sci 2006; 15: 2558-2567.
126. Schlessinger A, Ofran Y, Yachdav G, Rost B. Epitome: database of structure-inferred antigenic epitopes. Nucleic Acids Res 2006; 34: D777-D780.
127. Singh MK, Srivastava S, Raghava GPS, Varsheny GC. HaptenDB: a comprehensive database of haptens, carrier proteins and anti-hapten antibodies. Bioinformatics 2006; 22: 253-255.
128. Blythe MJ, Doytchinova IA, Flower DR. JenPep: a database of quantitative functional peptide data for immunology. Bioinformatics 2002; 18: 434-439.
129. Marchler-Bauer A, Addess KJ, Chappey C, et al. MMDB: Entrez's 3D structure database. Nucleic Acids Res 1999; 27: 240-243.
130. Schneidman-Duhovny D, Inbar Y, Polak V, et al. Taking geometry to its edge: fast unbound rigid (and hinge-bent) docking. Protein 2003; 52(1): 107-112.
131. Kufareva I, Budagyan L, Raush E, Totrov M, Abagyan R. PIER: protein interface recognition for structural proteomics. Proteins 2007; 67(2): 400-417.
132. Bradford JR, Westhead DR. Improved prediction of protein-protein binding sites using a support vector machines approach. Bioinformatics 2005; 21: 1487-1494.
133. Neuvirth H, Raz R, Schreiber G. ProMate: a structure based prediction program to identify the location of protein-protein binding sites. J Mol Biol 2004; 338(1): 181-199.
134. Allcorn LC, Martin AC. SACS - self-maintaining database of antibody crystal structure information. Bioinformatics 2002; 18(1): 175-181.
135. Ivanciuc O, Schein CH, Braun W. SDAP: database and computational tools for allergenic proteins. Nucleic Acids Res 2003; 31: 359-362.
136. Robinson HL, Amara RR. T cell vaccines for microbial infections. Nat Med 2005; 11: S25-S32.
137. Doytchinova I, Flower DR. Towards the quantitative prediction of T-cell epitopes: CoMFA and CoMSIA studies of peptides with affinity to class I MHC molecule HLA-A*0201. J. Med. Chem 2001; 44: 3572-3581.
138. Zhao B, Mathura VS, Rajaseger G, Moochhala S, Sakharkar MK, Kangueane P. A novel MHCp binding prediction model. Human Immunology 2003; 64(12): 1123-1143.
139. Adams HP, Koziol JA. Prediction of binding to MHC class I molecules. J Immunol Methods 1995; 185(2): 181-190.
140. Bhasin M, Raghava GPS. A hybrid approach for predicting promiscuous MHC class I restricted T cell epitopes. J Biosci 2007; 32: 31-42.
141. Zeng J, Treutlein HR, Rudy GB. Predicting sequences and structures of MHC-binding peptides: a computational combinatorial approach. Journal of Computer-Aided Molecular Design 2001; 15(6): 573-586.
142. Antes I, Siu SW, Lengauer T. DynaPred. Bioinformatics 2006; 22(14): e16-e24.
143. Logean A, Rognan D. Recovery of known T-cell epitopes by computational scanning of a viral genome. Journal of Computer-Aided Molecular Design 2002; 16(4): 229-243.
144. Noguchi H, Kato HT, Matsubara Y, et al. Hidden Markov model-based prediction of antigenic peptides that interact with MHC class II molecules. Journal of Bioscience and Bioengineering 2002; 94(3): 264-270.
145. Sturniolo T, Bono E, Ding J, et al. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat. Biotechnol 1999; 1: 555-561.
146. Mallios RR. Class II MHC quantitative binding motifs derived from a large molecular database with a versatile iterative stepwise discriminant analysis meta-algorithm. Bioinformatics 1999; 15: 432-439.
147. Cui J, Han LY, Lin HH, et al. Prediction of MHC-binding peptides of flexible lengths from sequence-derived structural and physicochemical attributes. Mol Immunol 2007; 44(5): 866-877.
148. Dönnes P, Elofsson A. Prediction of MHC class I binding peptides, using SVMHC. BMC Bioinformatics 2002; 3: 25.
149. Schueler-Furman O, Altuvia Y, Sette A, Margalit H. Structure-based prediction of binding peptides to MHC class I molecules: Application to a broad range of MHC alleles. Protein Sci 2000; 9: 1838-1846.